Evidence map›Paper›PMID 38531650›Full record

ReviewRNA (New York, N.Y.)2024

Recent developments, opportunities, and challenges in the study of mRNA pseudouridylation.

Wendy V Gilbert

Abstract readReview
In one paragraph

Review in RNA (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. The impact of psuedouridine modification on human tRNA.Biochemical Society transactions · 2026
    Review
  5. Pseudouridine synthase 7 as a context-specific therapeutic target in cancer.The Journal of pharmacology and experimental therapeutics · 2026
    Review
  6. RNA modifications in cancer and their detection: a review.Japanese journal of clinical oncology · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Functions and therapeutic applications of pseudouridylation.Nature reviews. Molecular cell biology · 2025
    Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Wendy V GilbertDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06520, USA wendy.gilbert@yale.edu.ORCID 0009-0004-4082-5266

Funding

Regulation and Function of snoRNA GenesR01GM101316 · NIGMS · YALE UNIVERSITY · PI Wendy Victoria Gilbert · 2014 to 2026
$3.9M
NIGMS NIH HHS R01 GM101316
6 · The paper itself

Abstract

Pseudouridine is an abundant mRNA modification found in diverse organisms ranging from bacteria and viruses to multicellular plants and humans. New developments in pseudouridine profiling provide quantitative tools to map mRNA pseudouridylation sites. Sparse biochemical studies establish the potential for mRNA pseudouridylation to affect most stages of the mRNA life cycle from birth to death. This recent progress sets the stage for deeper investigations into the molecular and cellular functions of specific mRNA pseudouridines, including in disease.

Indexed as

ResearchRNA, MessengerAnimalsHumansIntramolecular TransferasesProtein BindingProtein BiosynthesisRNA-Binding ProteinsRNA PrecursorsTranscription, GeneticIntramolecular Transferasespseudouridine synthasesRNA-Binding ProteinsRNA, MessengerRNA PrecursorsmRNA modificationpseudouridine

Identifiers

PMID38531650
PMCPMC11019745

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.